Peripartum Cesarean Hysterectomy for Placenta Percreta

The aim of this study is to address the possible preoperative determinants of extrauterine diseases in cases of placenta previa percreta and to compare the operative and postoperative characteristics of cases with and without extrauterine disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Placenta Accreta Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Placenta Diseases Placenta Previa Pregnancy Complications Urogenital Diseases

Sex eligibility

Female

Study type

Observational

Primary location

Mansoura University Hospital

Al Mansurah, Dakahlia Governorate, 35111, Egypt

About this study

This will be a retrospective study of the data of women who underwent cesarean hysterectomy on placenta previa percreta who were classified as Federation of Gynecology and Obstetrics (FIGO) grade 3. Women without extrauterine disease (FIGO grade 3a) will be compared to women with extrauterine disease (FIGO grades 3b and 3c)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women who underwent cesarean hysterectomy on placenta previa percreta (FIGO grade 3).

Exclusion criteria

Medical conditions complicating pregnancy.
Blood diseases or bleeding tendencies

Treatment and study plan

Cesarean Hysterectomy

Procedure

Cesarean hysterectomy due to placenta previa percreta with no extrauterine disease (FIGO grade 3a) or with extrauterine disease (FIGO grades 3b and 3c)

Primary outcomes

Estimated amount of intraoperative blood loss

Time frame: From start to end of operation

Calculated amount of blood loss during the operation

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Official study title

Peripartum Cesarean Hysterectomy for Placenta Percreta: a Retrospective Analysis of Cases With and Without Extrauterine Disease

Important dates

Study start: 2018
Primary completion: 2023
Study completion: 2023
First posted: Aug 7, 2023
Registry last updated: Aug 7, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed